JP2017506623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506623A5 JP2017506623A5 JP2016549334A JP2016549334A JP2017506623A5 JP 2017506623 A5 JP2017506623 A5 JP 2017506623A5 JP 2016549334 A JP2016549334 A JP 2016549334A JP 2016549334 A JP2016549334 A JP 2016549334A JP 2017506623 A5 JP2017506623 A5 JP 2017506623A5
- Authority
- JP
- Japan
- Prior art keywords
- bag3
- vector
- expression
- bcl2
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461934483P | 2014-01-31 | 2014-01-31 | |
| US61/934,483 | 2014-01-31 | ||
| PCT/US2015/013926 WO2015117010A2 (en) | 2014-01-31 | 2015-01-30 | Bag3 as a target for therapy of heart failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019191740A Division JP7079761B2 (ja) | 2014-01-31 | 2019-10-21 | 心不全の治療のための標的としてのｂａｇ３ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017506623A JP2017506623A (ja) | 2017-03-09 |
| JP2017506623A5 true JP2017506623A5 (enExample) | 2018-05-24 |
| JP6920818B2 JP6920818B2 (ja) | 2021-08-18 |
Family
ID=53757927
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549334A Active JP6920818B2 (ja) | 2014-01-31 | 2015-01-30 | 心不全の治療のための標的としてのｂａｇ３ |
| JP2019191740A Active JP7079761B2 (ja) | 2014-01-31 | 2019-10-21 | 心不全の治療のための標的としてのｂａｇ３ |
| JP2022083707A Active JP7558218B2 (ja) | 2014-01-31 | 2022-05-23 | 心不全の治療のための標的としてのｂａｇ３ |
| JP2024160090A Pending JP2024175055A (ja) | 2014-01-31 | 2024-09-17 | 心不全の治療のための標的としてのｂａｇ３ |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019191740A Active JP7079761B2 (ja) | 2014-01-31 | 2019-10-21 | 心不全の治療のための標的としてのｂａｇ３ |
| JP2022083707A Active JP7558218B2 (ja) | 2014-01-31 | 2022-05-23 | 心不全の治療のための標的としてのｂａｇ３ |
| JP2024160090A Pending JP2024175055A (ja) | 2014-01-31 | 2024-09-17 | 心不全の治療のための標的としてのｂａｇ３ |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11236389B2 (enExample) |
| EP (2) | EP3812473A1 (enExample) |
| JP (4) | JP6920818B2 (enExample) |
| CA (2) | CA3228845A1 (enExample) |
| DK (1) | DK3099333T3 (enExample) |
| ES (1) | ES2838804T3 (enExample) |
| HU (1) | HUE052814T2 (enExample) |
| PT (1) | PT3099333T (enExample) |
| SI (1) | SI3099333T1 (enExample) |
| WO (1) | WO2015117010A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE052814T2 (hu) * | 2014-01-31 | 2021-05-28 | Temple Univ Of The Commonwealth System | A szívelégtelenség terápiájához célfehérjeként alkamazott BAG3 |
| EP3337518A4 (en) * | 2015-08-17 | 2019-06-12 | Temple University Of The Commonwealth System Of Higher Education | BAG3 COMPOSITIONS AND METHOD |
| CN105769900A (zh) * | 2016-03-22 | 2016-07-20 | 山西大学 | Bag3基因在制备抗膀胱癌药物中的应用 |
| KR101804678B1 (ko) | 2016-05-30 | 2017-12-04 | 가톨릭대학교 산학협력단 | Bis 억제제 스크리닝용 마커, 이를 포함하는 스크리닝 키트 및 이를 이용한 bis 억제제 스크리닝 방법 |
| IT201600069391A1 (it) * | 2016-07-04 | 2016-10-04 | Univ Degli Studi Di Salerno | Uso della proteina bag3 e suoi frammenti peptidici per il controllo dell’omeostasi vascolare |
| EP3496726A4 (en) * | 2016-08-11 | 2020-05-06 | Temple University Of The Commonwealth System Of Higher Education | ISCHEMIA / REPERFUSION DAMAGE |
| US20190328836A1 (en) * | 2017-01-09 | 2019-10-31 | Duke University | Methods for treating ischemic injury |
| IT201700113648A1 (it) * | 2017-10-10 | 2019-04-10 | Biouniversa Srl | Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases |
| WO2019020734A1 (en) | 2017-07-28 | 2019-01-31 | Biouniversa S.R.L. | ANTI-BAG3 ANTIBODIES AS THERAPEUTIC REAGENTS IN CARDIOVASCULAR DISEASES |
| CN112105630A (zh) * | 2018-02-15 | 2020-12-18 | T·比约尔克隆德 | 经修饰的病毒衣壳 |
| WO2019237002A1 (en) * | 2018-06-08 | 2019-12-12 | Temple University - Of The Commonwealth System Of Higher Education | Optimizing bag3 gene therapy |
| CN113544508A (zh) * | 2018-11-08 | 2021-10-22 | 迈阿密大学 | 扩张型心肌病中确定对细胞疗法反应性的方法 |
| US20220088127A1 (en) * | 2019-01-15 | 2022-03-24 | Temple University - Of The Commonwealth System Of Higher Education | Targeting the bag family for the treatment of neurodegenerative disease |
| SG11202110607WA (en) | 2019-04-01 | 2021-10-28 | Tenaya Therapeutics Inc | Adeno-associated virus with engineered capsid |
| CN115698304A (zh) | 2020-10-09 | 2023-02-03 | 特纳亚治疗股份有限公司 | 亲斑蛋白-2基因疗法的方法和组合物 |
| CA3228581A1 (en) * | 2021-08-12 | 2023-02-16 | Arthur M. Feldman | Retrograde coronary venous or sinus administration of therapeutics |
| IL312509A (en) * | 2021-10-22 | 2024-07-01 | Univ Loyola Chicago | BAG3 methods and uses for treating inflammation |
| IL313427A (en) * | 2021-12-10 | 2024-08-01 | Aavantibio Inc | Methods and preparations for treating BAG-3-related cardiomyopathy with a viral vector |
| WO2023147558A2 (en) * | 2022-01-28 | 2023-08-03 | Temple University - Of The Commonwealth System Of Higher Education | Crispr methods for correcting bag3 gene mutations in vivo |
| AU2023258039A1 (en) * | 2022-04-22 | 2024-11-21 | Spacecraft Seven, Llc | B-cell lymphoma 2–associated anthanogene 3 (bag3) gene therapy using aav vector |
| JP2025514489A (ja) * | 2022-05-03 | 2025-05-02 | テンプル ユニバーシティー オブ ザ コモンウェルス システム オブ ハイアー エデュケーション | 脳におけるｂａｇ３およびタンパク質品質管理 |
| AU2023342101A1 (en) * | 2022-09-16 | 2025-04-10 | Temple University Of The Commonwealth System Of Higher Education | Bag 3 methods and uses for treatment of cardiac amyloidosis |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| EP0260032B1 (en) | 1986-09-08 | 1994-01-26 | Ajinomoto Co., Inc. | Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| ATE151467T1 (de) | 1987-11-30 | 1997-04-15 | Univ Iowa Res Found | Durch modifikationen an der 3'-terminalen phosphodiesterbindung stabilisierte dna moleküle, ihre verwendung als nukleinsäuresonden sowie als therapeutische mittel zur hemmung der expression spezifischer zielgene |
| US5403711A (en) | 1987-11-30 | 1995-04-04 | University Of Iowa Research Foundation | Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
| US4907603A (en) | 1988-01-04 | 1990-03-13 | Bertha D. Chambers | Safety smoke |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5623065A (en) | 1990-08-13 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Gapped 2' modified oligonucleotides |
| US5459255A (en) | 1990-01-11 | 1995-10-17 | Isis Pharmaceuticals, Inc. | N-2 substituted purines |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| US5220007A (en) | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
| US5218105A (en) | 1990-07-27 | 1993-06-08 | Isis Pharmaceuticals | Polyamine conjugated oligonucleotides |
| US5138045A (en) | 1990-07-27 | 1992-08-11 | Isis Pharmaceuticals | Polyamine conjugated oligonucleotides |
| US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
| US5670113A (en) | 1991-12-20 | 1997-09-23 | Sibia Neurosciences, Inc. | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
| US5700922A (en) | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| US5652355A (en) | 1992-07-23 | 1997-07-29 | Worcester Foundation For Experimental Biology | Hybrid oligonucleotide phosphorothioates |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| PT733059E (pt) | 1993-12-09 | 2001-03-30 | Univ Jefferson | Compostos e metodos para mutacoes dirigidas ao local em celulas eucarioticas |
| EP0745134A1 (en) | 1994-02-22 | 1996-12-04 | Danafarber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US5652356A (en) | 1995-08-17 | 1997-07-29 | Hybridon, Inc. | Inverted chimeric and hybrid oligonucleotides |
| CN103555677B (zh) | 2001-11-13 | 2018-01-30 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| EP1323733A1 (en) | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| US20030175958A1 (en) * | 2002-03-15 | 2003-09-18 | Reed John C. | Methods for using bag expression as a cell differentiation agent and marker |
| CA2715765A1 (en) | 2008-02-19 | 2009-08-27 | Celladon Corporation | Compositions for enhanced uptake of viral vectors in the myocardium |
| WO2010138263A2 (en) * | 2009-05-28 | 2010-12-02 | University Of Massachusetts | Novel aav 's and uses thereof |
| WO2012087835A2 (en) * | 2010-12-22 | 2012-06-28 | Boston Biomedical Research Institute | Compositions and methods for enhancing protein folding |
| WO2012107580A1 (en) | 2011-02-10 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | In vitro diagnosis method for predicting a predisposition to cardiomyopathy |
| HUE052814T2 (hu) | 2014-01-31 | 2021-05-28 | Temple Univ Of The Commonwealth System | A szívelégtelenség terápiájához célfehérjeként alkamazott BAG3 |
| CA3228581A1 (en) | 2021-08-12 | 2023-02-16 | Arthur M. Feldman | Retrograde coronary venous or sinus administration of therapeutics |
-
2015
- 2015-01-30 HU HUE15743948A patent/HUE052814T2/hu unknown
- 2015-01-30 DK DK15743948.0T patent/DK3099333T3/da active
- 2015-01-30 WO PCT/US2015/013926 patent/WO2015117010A2/en not_active Ceased
- 2015-01-30 JP JP2016549334A patent/JP6920818B2/ja active Active
- 2015-01-30 US US15/115,807 patent/US11236389B2/en active Active
- 2015-01-30 EP EP20208165.9A patent/EP3812473A1/en active Pending
- 2015-01-30 CA CA3228845A patent/CA3228845A1/en active Pending
- 2015-01-30 EP EP15743948.0A patent/EP3099333B8/en active Active
- 2015-01-30 PT PT157439480T patent/PT3099333T/pt unknown
- 2015-01-30 SI SI201531453T patent/SI3099333T1/sl unknown
- 2015-01-30 CA CA2975258A patent/CA2975258A1/en active Pending
- 2015-01-30 ES ES15743948T patent/ES2838804T3/es active Active
-
2019
- 2019-10-21 JP JP2019191740A patent/JP7079761B2/ja active Active
-
2020
- 2020-05-21 US US15/929,784 patent/US11542555B2/en active Active
-
2022
- 2022-05-23 JP JP2022083707A patent/JP7558218B2/ja active Active
- 2022-10-05 US US17/938,209 patent/US20230073246A1/en active Pending
-
2024
- 2024-09-17 JP JP2024160090A patent/JP2024175055A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017506623A5 (enExample) | ||
| DK2299275T3 (en) | Classification of oncofetal fetronectin level for pregnancy-related indications | |
| RU2730836C2 (ru) | Вычислительный анализ биологических данных с применением многообразия и гиперплоскости | |
| CN109661578B (zh) | 用于区分细菌和病毒感染的蛋白质特征 | |
| US7659243B2 (en) | Treatment of ALS and variants thereof consisting of primary lateral sclerosis (PLS) or spinal muscular atrophy (SMA) | |
| JP7598843B2 (ja) | 腎疾患及び歯周疾患を検出及び診断するための方法及び組成物 | |
| EP1354199A2 (en) | Diagnosis and treatment of multiple sclerosis | |
| JP2013511732A (ja) | 神経障害の診断、診断補助および／またはその進行のモニタリングのための方法、キットおよび試薬 | |
| CN112920275B (zh) | 可特异性结合sST2的结合蛋白、试剂和试剂盒 | |
| CN116322750A (zh) | 抗原特异性t细胞受体和嵌合抗原受体以及用于癌症免疫疗法的免疫信号传导调节中的使用方法 | |
| CN115703837B (zh) | 一种抗生长刺激表达基因2蛋白的重组抗体 | |
| CN114107482A (zh) | 肺动脉高压突变基因及其应用 | |
| JP2010539891A (ja) | 心臓血管及び血栓性の危険性の決定のためのｃｌｅｃ１ｂの使用 | |
| JP2009506301A (ja) | Ｐｉｆファミリーの新たなタンパク質アイソフォーム及びその使用 | |
| JP2007523640A5 (enExample) | ||
| TW201643191A (zh) | 新穎的ｉｇｆ－１ｒ抗體及其用於癌症診斷之用途（一） | |
| CN104650214B (zh) | 肺动脉高压致病基因acvrl1突变位点及其应用 | |
| CN112940130A (zh) | 能够特异性结合mpo的结合蛋白、其用途、试剂、试剂盒和检测mpo的方法 | |
| CN110320367A (zh) | 基于lag-3的诊断试剂盒及其在帕金森病诊断产品上的应用 | |
| WO2001063293A2 (en) | Diagnosis and treatment of schizophrenia | |
| RU2000119129A (ru) | Молекула днк, кодирующая мутантный препронейропептид y, мутантный сигнальный пептид и их применения | |
| TW201643192A (zh) | 新穎的ｉｇｆ－１ｒ抗體及其用於癌症診斷之用途（二） | |
| KR102476905B1 (ko) | 허혈성 질환 진단 또는 예후 진단용 바이오마커 | |
| CN114085900B (zh) | 与遗传性肾小球疾病相关的突变基因及其应用 | |
| CN114875130B (zh) | Lpin3蛋白或编码lpin3蛋白的基因在作为急性肾损伤的生物标志物中的应用 |